Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Cash & Current Investments: 2021-2022

Historic Cash & Current Investments for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to -$11.3 million.

  • Cardiol Therapeutics' Cash & Current Investments fell 197.27% to -$11.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $119.9 million, marking a year-over-year change of. This contributed to the annual value of $66.9 million for FY2021, which is N/A change from last year.
  • As of Q3 2022, Cardiol Therapeutics' Cash & Current Investments stood at -$11.3 million, which was down 10.64% from -$10.2 million recorded in Q2 2022.
  • Cardiol Therapeutics' 5-year Cash & Current Investments high stood at $74.8 million for Q1 2022, and its period low was -$11.3 million during Q3 2022.
  • For the 2-year period, Cardiol Therapeutics' Cash & Current Investments averaged around $21.4 million, with its median value being $11.6 million (2021).
  • Over the last 5 years, Cardiol Therapeutics' Cash & Current Investments had its largest YoY gain of 2,280.88% in 2022, and its largest YoY loss of 197.27% in 2022.
  • Over the past 2 years, Cardiol Therapeutics' Cash & Current Investments (Quarterly) stood at $66.6 million in 2021, then crashed by 197.27% to -$11.3 million in 2022.
  • Its Cash & Current Investments stands at -$11.3 million for Q3 2022, versus -$10.2 million for Q2 2022 and $74.8 million for Q1 2022.